Abstract:Background Acute lung injury (ALI) is a life-threatening condition characterized by excessive pulmonary inflammation, yet its precise pathophysiology remains elusive. Pyroptosis, a programmed cell death mechanism controlled by gasdermin D (GSDMD), has been linked to the etiology of ALI. This study investigated the regulatory functions of the transcription factor E-twenty-six variant gene 5 (ETV5) and GSDMD in ALI. Methods Lipopolysaccharide (LPS) was used to treat BEAS-2B cells (50 mmol/mL) and establish an LPS-induced mouse model of ALI (by intratracheal administration, 3 mg/kg). Protein-protein docking, immunofluorescence analysis, western blotting, real-time quantitative polymerase chain reaction, and dual-luciferase reporter gene assay were used to examine ETV5-mediated negative feedback regulation of GSDMD and its effects on pyroptosis and ALI. Results Our results showed that the physiological function of ETV5 was reduced by its downregulated expression, which impeded its nuclear translocation in ALI mice. Increased pyroptosis and enhanced production of inflammatory cytokines were associated with LPS-induced ALI. ETV5 overexpression in LPS-treated BEAS-2B cells decreased the expression of total and membrane-bound GSDMD, negatively regulated GSDMD, and prevented pyroptosis. The expression of inflammatory cytokines was subsequently reduced due to this inhibition, which, in turn, reduced ALI. Molecular docking analysis and dual-luciferase reporter gene assay results indicated a direct interaction between ETV5 and GSDMD, which inhibited GSDMD production. Conclusion Our results indicate that ETV5 inhibits pyroptosis, decreases the expression of inflammatory cytokines, and negatively regulates GSDMD expression to ameliorate ALI symptoms.

E3 Ubiquitin Ligase SYVN1 is a Key Positive Regulator for GSDMD-mediated Pyroptosis

USP18 Antagonizes Pyroptosis by Facilitating Selective Autophagic Degradation of Gasdermin D

The Regulation and Modification of GSDMD Signaling in Diseases

Crosstalk of HDAC4, PP1, and GSDMD in controlling pyroptosis

Palmitoylation of gasdermin D directs its membrane translocation and pore formation in pyroptosis

GSDMB promotes non-canonical pyroptosis by enhancing caspase-4 activity.

Gasdermin D in pyroptosis

The gasdermin family: emerging therapeutic targets in diseases

Transcription factor Sp1 transcriptionally enhances GSDME expression for pyroptosis

TRIM21 regulates pyroptotic cell death by promoting Gasdermin D oligomerization

Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors

Gasdermin D restricts anti-tumor immunity during PD-L1 checkpoint blockade

Pyroptosis Inhibition Alleviates Acute Lung Injury via E-twenty-Six Variant Gene 5-Mediated Downregulation of Gasdermin D

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

Precise Orchestration of Gasdermins' Pore-Forming Function by Posttranslational Modifications in Health and Disease

Gasdermin D is activated but does not drive neurodegeneration in SOD1G93A model of ALS: Implications for targeting pyroptosis

Pyroptosis executor gasdermin D plays a key role in scleroderma and bleomycin-induced skin fibrosis

Protein phosphatase 1 regulates phosphorylation of Gasdermin D and pyroptosis

Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway

Gasdermin-E Mediated Pyroptosis—A Novel Mechanism Regulating Migration, Invasion and Release of Inflammatory Cytokines in Rheumatoid Arthritis Fibroblast-like Synoviocytes

Ubiquitin-independent degradation of Bim blocks macrophage pyroptosis in sepsis-related tissue injury